Torren Management’s Maravai LifeSciences MRVI Stock Holding History

Torren Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,462	Closed	-$11.3K	–	1267
2025 Q4	$11.3K	Buy	+3,462	New	+$11.7K	0.01%	737

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Torren Management's MRVI Position: Q1 2026 in Review

Torren Management sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 3,462 shares — an estimated $11.3K sold.

Torren Management first reported a position in MRVI in Q4 2025 and held it in 1 quarter. The position peaked at $11.3K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Torren Management reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
Torren Management sold 3,462 Maravai LifeSciences shares in Q1 2026, an estimated $11.3K.
Torren Management first reported a position in Maravai LifeSciences in Q4 2025 and held it in 1 quarter.
Torren Management's Maravai LifeSciences position peaked at $11.3K in Q4 2025.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.